Martin Charles Faulkes, Director at VOLITIONRX LTD (VNRX), bought 55,000 shares at $2.10 ($116K) on 2022-12-16, disclosed to the SEC on 2022-12-19.
Open-market purchase of $116k VNRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| VNRX | BUY | 2019-08-28 | $38K | — | Filing → |
| VNRX | BUY | 2019-08-16 | $197K | — | Filing → |
| VNRX | BUY | 2019-06-13 | $461K | — | Filing → |